The Medicines Company
50 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol (NCT03399370) | The Medicines Company | 2017-12-21 |
| Trial to Evaluate the Effect of Inclisiran Treatment on Low Density Lipoprotein Cholesterol (LDL-C) in Subjects With Heterozygous Familial Hypercholesterolemia (HeFH) (NCT03397121) | The Medicines Company | 2017-11-28 |
| Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol (NCT03400800) | The Medicines Company | 2017-11-01 |
Track The Medicines Company automatically
Every clearance here is in the API, with alerts when new ones post.